2000
DOI: 10.1016/s0021-9150(00)00368-3
|View full text |Cite
|
Sign up to set email alerts
|

Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

2
31
0

Year Published

2003
2003
2020
2020

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(33 citation statements)
references
References 31 publications
2
31
0
Order By: Relevance
“…These results are in agreement with a previous study, which found that the mean CRP concentrations in patients with stable or progressing disease (indicating severe disease) did not differ significantly from those in controls, in contrast to sIL2R (16 ). It appears that the acute-phase response, reflected through increased CRP and SAA concentrations, can be expected only in patients with active disease, including Löfgren syndrome (8,10,16 ).…”
Section: Discussion Diagnostic Performance Of the Evaluated Markerssupporting
confidence: 92%
See 1 more Smart Citation
“…These results are in agreement with a previous study, which found that the mean CRP concentrations in patients with stable or progressing disease (indicating severe disease) did not differ significantly from those in controls, in contrast to sIL2R (16 ). It appears that the acute-phase response, reflected through increased CRP and SAA concentrations, can be expected only in patients with active disease, including Löfgren syndrome (8,10,16 ).…”
Section: Discussion Diagnostic Performance Of the Evaluated Markerssupporting
confidence: 92%
“…High-sensitivity CRP (hs-CRP) methods have recently been introduced to accurately monitor minor increases in serum CRP (9 ), but no studies evaluating hs-CRP in sarcoidosis have been reported. Increased SAA has also been shown to be independently associated with sarcoidosis activity (10 ). SAA appears to be less sensitive to immunosuppressive drugs, such as corticosteroids, and therefore has been recommended in the follow-up of patients to whom such drugs have been administered (6 ).…”
mentioning
confidence: 99%
“…Secreted A-SAA associates with high-density lipoprotein (HDL), displacing apolipoprotein AI (Apo-AI) and yielding lipoprotein fractions, including SAA, lipidpoor Apo-AI, and lipoprotein-free SAA (4,5). Persistently high SAA usually indicates reduced Apo-AI and HDL cholesterol as a result of increases in HDL metabolism (5). However, during the acute-phase response, serum levels of A-SAA increase up to 1000-fold, saturating HDL and allowing lipid-free A-SAA to circulate.…”
mentioning
confidence: 99%
“…At elevated concentrations, SAA displaces apoA-I and produces lipoprotein fractions containing predominantly SAA, lipid-poor apoA-I, and lipoprotein-free SAA. Persistently high SAA levels are usually associated with significantly reduced apoA-I and HDL cholesterol levels due to enhanced HDL metabolism (18,19). SAA may also act as a signal for redirecting HDL to the sites of tissue destruction and cholesterol accumulation (20).…”
mentioning
confidence: 99%